Ageas was spun out of Fortis during the financial crisis after a consortium including Banco Santander and Royal Bank of Scotland launched a failed bid for ABN Amro... Show more
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where AGESY advanced for three days, in of 337 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 228 cases where AGESY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.925) is normal, around the industry mean (2.084). P/E Ratio (6.974) is within average values for comparable stocks, (15.920). Projected Growth (PEG Ratio) (1.914) is also within normal values, averaging (6.024). Dividend Yield (0.074) settles around the average of (0.054) among similar stocks. P/S Ratio (0.735) is also within normal values, averaging (1.427).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 42, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AGESY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry MultiLineInsurance
A.I.dvisor indicates that over the last year, AGESY has been loosely correlated with ALIZY. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if AGESY jumps, then ALIZY could also see price increases.
Ticker / NAME | Correlation To AGESY | 1D Price Change % | ||
---|---|---|---|---|
AGESY | 100% | -6.52% | ||
ALIZY - AGESY | 59% Loosely correlated | -8.03% | ||
AXAHY - AGESY | 55% Loosely correlated | -7.39% | ||
AVVIY - AGESY | 54% Loosely correlated | -7.25% | ||
ARZGY - AGESY | 50% Loosely correlated | -7.49% | ||
AEG - AGESY | 46% Loosely correlated | -8.44% | ||
More |